EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Hindustan Bio Sciences's enterprise value is ₹113.48 Mil.
Hindustan Bio Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1.37 Mil. Therefore, Hindustan Bio Sciences's EV-to-EBITDA for today is 82.83.
The historical rank and industry rank for Hindustan Bio Sciences's EV-to-EBITDA or its related term are showing as below:
BOM:532041'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -262.75 Med: -1.56 Max: 423.06
Current: 82.83
During the past 13 years, the highest EV-to-EBITDA of Hindustan Bio Sciences was 423.06. The lowest was -262.75. And the median was -1.56.
BOM:532041's EV-to-EBITDA is ranked worse than 93.99% of 715
companies
in the Drug Manufacturers industry
Industry Median: 14.57
vs BOM:532041: 82.83
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Hindustan Bio Sciences's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hindustan Bio Sciences's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Hindustan Bio Sciences's EV-to-EBITDA falls into.
Hindustan Bio Sciences's current Enterprise Value is ₹113.48 Mil.
Hindustan Bio Sciences's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.37 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hindustan Bio Sciences (BOM:532041) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Hindustan Bio Sciences's PE Ratio for today is calculated as:
Hindustan Bio Sciences's share price for today is ₹8.55.
Hindustan Bio Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.140.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Hindustan Bio Sciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Hindustan Bio Sciences (BOM:532041) Business Description
Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:532041 has been successfully added to your 